|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1992-11-23
|
|
pubmed:abstractText |
Based on the results of our phase I study that demonstrated the antitumor activity of taxol in a previously treated patient with ovarian cancer, a phase II study was conducted to evaluate the efficacy of taxol in patients with metastatic ovarian cancer and to evaluate further the toxicity of taxol in this group of patients.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1748-53
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:1357110-Adenocarcinoma,
pubmed-meshheading:1357110-Adult,
pubmed-meshheading:1357110-Aged,
pubmed-meshheading:1357110-Aged, 80 and over,
pubmed-meshheading:1357110-Female,
pubmed-meshheading:1357110-Follow-Up Studies,
pubmed-meshheading:1357110-Humans,
pubmed-meshheading:1357110-Infusions, Intravenous,
pubmed-meshheading:1357110-Middle Aged,
pubmed-meshheading:1357110-Ovarian Neoplasms,
pubmed-meshheading:1357110-Paclitaxel,
pubmed-meshheading:1357110-Treatment Outcome
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma.
|
|
pubmed:affiliation |
Division of Medical Oncology, Albert Einstein Cancer Center, Bronx, NY 10461.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Clinical Trial, Phase II
|
